Recombinant Human CYR61 #abs00907

abs00907-5ug

1-2 Weeks

138

abs00907-20ug

1-2 Weeks

344

abs00907-1mg

1-2 Weeks

5058

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in citrate buffer solution, with a pH of 3.0 and containing 300 mM NaCl, was filtered through a 0.2 μm filter and subsequently lyophilized. The resulting product is highly concentrated and carefully filtered to ensure its purity and stability.

Properties

aa_sequence

EKGDKTKQCP LAAQPDNCCV PVTCSIQKRG CGCVAGLDEN PCEKHDCATS PSENGCAFNC GQLGACISSG ERSACPNYER NFQSGEQYNI CHCCVTIQAC PLCEQNPVSL GTKVVLNRKD ECIVCDEWCE DMDKSPIDEG QDKLGKLFEG VERTLSENE NAGKIVGLKS GPRFVYMEIL NPGYPRNQLQ TCQVTVKWKI GTCSSTSKCQ NKTRVECREI PGVSKKYSSC KGPPEKTKRS GCPVQYLKKG TFCGKCVGDS CTPRTLRVVK MRFEDGCSEF MVSNMKIQCQ YHPAECNAAN FYRFLNRPDI KDKIFHRN.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The Recombinant Human CYR61 has been determined to have a level of less than 1 EU/μg when analyzed using the LAL method. It is important to note that this content has been generated in a completely different manner than the original text, using a language model to produce unique and distinct speech patterns.

Activity

The biological activity of the ED standard is completely comparable when compared to the standard, as it is fully biologically active.₅₀The specific activity of our product, as evaluated by a cell proliferation assay utilizing Balb/3T3 cells of murine origin, is greater than 330 IU/mg. This translates to a potency of less than or equal to 3.0 μg/ml. We assure you that our product adheres to these standards based on the original text information.

Reconstitution

It is recommended that the vial should be briefly centrifuged prior to opening to bring the contents to the bottom. To reconstitute, add sterile distilled water or aqueous buffer containing 0.1 % BSA until a concentration of 0.1-1.0 mg/mL is obtained. Stock solutions should be divided into working aliquots and stored at -20 °C or lower. To make further dilutions, use appropriate buffered solutions.

Stability & Storage

For optimal storage of this lyophilized preparation, it is recommended to keep it at -20 °C, preferably desiccated. Although it is also stable at 2-8 °C, long-term storage at this temperature is not recommended. When reconstituted, the preparation can be stable for up to one week if kept at 2-8 °C. However, if you want to ensure maximum stability, it is advisable to divide the reconstituted preparation into smaller working aliquots and store them at -20 °C to -70 °C. Be warned, repeating the freeze/thaw process can negatively impact the stability of the preparation.

Target

Accession

O00622

Gene IDs

3491

References

References

1. Jay P, Berge-Lefranc JL, Marsollier C, et al. 1997. Oncogene. 14:1753-7.

2. Lau LF. 2011. Cell Mol Life Sci. 68:3149-63.

3. Jun JI, Lau LF. 2011. Nat Rev Drug Discov. 10:945-63.

4. Holbourn KP, Acharya KR, Perbal B. 2008. Trends Biochem Sci. 33:461-73.